Biopharmaceutical Logistics Market – Industry Analysis and Forecast (2022-2029)

Biopharmaceutical Logistics Market is anticipated to reach US$ 241.34 Bn by 2029 from US$ 115.07 Bn in 2021 at a CAGR of 9.7 % during a forecast period.
Biopharmaceutical Logistics Market Overview
Biopharmaceuticals are considered complicated products that require special treatment. Precision medicines and gene therapies need a supply chain controlled by temperature. The biopharmaceutical market is bound to grow with a growing number of precision medicines and gene therapies. In the field of efficiency and temperature-sensitive pharmaceutical products, outsourced logistics services provide pharmaceutical firms with various advantages.

North America and Europe are the market leaders. This is because these countries have a high volume of biopharmaceutical exports and imports. The introduction of innovative technologies for better transportation and warehousing in the supply chain is also driving the growth of the market in the region.To know about the Research Methodology :- Request Free Sample Report
Biopharmaceutical Logistics Market Dynamics
The rise in demand for household healthcare items, as well as the growing need for quick medical assistance, are both driving the market forward. The market is also growing due to the increased development of biologics, vaccines, and hormone treatments, all of which require cold chain transport. High sales of pharmaceutical items drive the demand of global export-import of Bio-pharmaceutical products in the bio-pharmaceutical logistics market. Thus, the investment rate in the R&D segment of the biopharmaceutical market is expected to increase significantly during the forecast period.

The market is also growing due to the increasing trend of outsourcing logistical operations, as well as rapid technical improvements in logistics. Data mining, mobile cloud solutions, and real-time monitoring are some of the technologies that have contributed to the market's positive growth.

Besides, these monitoring solutions aid logistic companies by sending warnings that allow them to obtain information needed to carry out emergency plans. As a result, the adoption of these solutions is likely to drive market growth during the forecast period.

However, the high operational costs of maintaining temperature-sensitive products may hamper the market's overall growth during the forecast period.
COVID-19 Impact on the Biopharmaceutical Logistics Market
COVID pandemic has a major impact on the market in terms of sales as more than 44% of sales of units are hampered owing to disruption in transport capabilities of the manufacturers due to stringent norms of lockdown and increasing safety concerns. Furthermore, supply chain interruptions, demand destruction, and changes in customer behavior owing to stringent lockdown conditions across the globe have impacted the Biopharmaceutical Logistics Market.

During the COVID -19 pandemic, demand for cellular therapies, vaccines, and blood products in the biopharmaceutical market increased drastically. These pharmaceutical products were transported by air freight with minimal damage, which is especially significant for temperature-sensitive vaccinations and critical biologic medications. This also increased the trade of conventional and over-the-counter medicines globally, which had a positive impact on the growth of the biopharmaceutical logistics market during the pandemic.
Biopharmaceutical Logistics Market Segmentation Analysis
By Product, the non-cold chain logistics segment dominated the market, with market size of US$ 67,293.15 Mn. in 2021 and to reach US$ xx Mn. by 2029, with a CAGR of xx%.

The cold chain segment is expected to have the largest market share. This growth is attributed to an increased demand for temperature-controlled products, requiring accurate temperature control logistics services to guarantee the effectiveness of the products. Telematics is also being utilized to increase the efficiency, connection, and security of their transportation items in the field of cold-chain biopharmaceutical logistics.

By Application, the air shipping segment dominated the market, with a market size of US$ xx Mn. in 2021 and to reach US$ xx Mn. by 2029, with a CAGR of xx%. When compared to other modes of cold logistics transit, air transportation has the highest share, with all of the required precision in the transport. Airfreight is the fastest route to carry pharmaceutical products with minimal damage, which is especially important for temperature-sensitive vaccines and crucial biologic pharmaceuticals. However, because air transport has a volume constraint, sea shipping, and road shipping is expected to overtake air shipping in terms of volume increase during the forecast period.
Biopharmaceutical Logistics Market Regional Insights
In 2021, the North American region had the largest market share of 37% in the Biopharmaceutical Logistics Market. This is owing to the vast number of pharmaceuticals export and importation markets in the region. Also, technological development, warehousing, and transportation in the supply chain are expected to drive the growth of the market during the forecast period. Europe is another important pharmaceutical market, with a revenue of USD 215 million in 2021. It is the world's second-largest pharmaceutical market.

The Asia Pacific is expected to grow at a rapid pace. This is due to the rising need for medicines among the region's aging population and the increasing number of diseases. The increasing demand for pharmaceuticals and personal protective equipment (PPE) as a result of COVID-19 is an important driver of regions growth

Leading market key players are working to demonstrate the opportunity to the car rental business market.

Major players are involved in adopting maintainable strategies to gain competitive edges such as new product launches, product up-gradation, and M&A, collaborative agreements. For example, In January 2021, FedEx announced the acquisition of Flying Cargo Group's International Express Business in Israel. The contract was signed to expand FedEx's portfolio and regional presence, allowing clients to make use of the company's global network.

In May 2021, United Parcel Service of America, Inc. announced the debut of the new UPS Premier, which will expand the company's healthcare capabilities. By utilizing next-generation sensor technologies and monitoring, UPS Premier aims to increase the service dependability and visibility of healthcare goods.
Biopharmaceutical Logistics Market Scope: Inquire before buying



Biopharmaceutical Logistics Market


Report Coverage
Details


Base Year:
2021
Forecast Period:
2022-2029


Historical Data:
2017 to 2021
Market Size in 2021:
US $ 115.07 Bn.


Forecast Period 2022 to 2029 CAGR:
9.7%
Market Size in 2029:
US $ 241.34 Bn.


 Segments Covered:
by Product
• Cold Chain Logistics
• Non-cold Chain Logistics


by Service
• Transportation
• Warehousing and Distribution
• Value Added Services


by Application
• Ground Shipping
• Sea Shipping
• Air Shipping


by End Users
• Pharmaceuticals
• Biopharmaceuticals
• Pharmacies
• Hospitals
• Clinics
• Supermarkets
• Others



Biopharmaceutical Logistics Market, by Region
• North America
• Asia pacific
• Europe
• Middle East and Africa
• South America
Biopharmaceutical Logistics Market Key Players
• FedEx Corporation
• Ceva Logistics LLC
• Amerisource Bergen Corporation
• Panalpina Group
• Kuehne and Nagel International AG
• XPO Logistics, Inc
• United Parcel Service, Inc
• Deutsche Post DHL Group
• DB Schenker
• C.H. Robinson Worldwide, Inc
• United Parcel Service of America
• DHL International GmbH
• SF Express
• DB Schenker
• C.H. Robinson

Frequently Asked Questions:

1. Which region has the largest share in Global Biopharmaceutical Logistics Market?
Ans: North American region holds the highest share in 2021.

2. What is the growth rate of Global Biopharmaceutical Logistics Market?
Ans: The Global Biopharmaceutical Logistics Market is growing at a CAGR of 9.7% during forecasting period 2022-2029.

3. What is scope of the Global Biopharmaceutical Logistics market report?
Ans: Global Biopharmaceutical Logistics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Biopharmaceutical Logistics market?
Ans: The important key players in the Global Biopharmaceutical Logistics Market are – FedEx Corporation, Ceva Logistics LLC, Amerisource Bergen Corporation, Panalpina Group, Kuehne and Nagel International AG, XPO Logistics, Inc, United Parcel Service, Inc, Deutsche Post DHL Group, DB Schenker, C.H. Robinson Worldwide, Inc, United Parcel Service of America, DHL International GmbH, SF Express, DB Schenker, and C.H. Robinson

5. What is the study period of this market?
Ans: The Global Biopharmaceutical Logistics Market is studied from 2021 to 2029.